BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28124179)

  • 1. Breast Cancer Risk Assessment at the Time of Screening Mammography: Perceptions and Clinical Management Outcomes for Women at High Risk.
    Morman NA; Byrne L; Collins C; Reynolds K; Bell JG
    J Genet Couns; 2017 Aug; 26(4):776-784. PubMed ID: 28124179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of breast cancer risk estimations, risk perception, and screening behaviors in obese rural Korean women.
    Park S; Cochrane BB; Koh SB; Chung C
    Oncol Nurs Forum; 2011 Nov; 38(6):E394-401. PubMed ID: 22037338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does genetic counseling have any impact on management of breast cancer risk?
    Watson M; Kash KM; Homewood J; Ebbs S; Murday V; Eeles R
    Genet Test; 2005; 9(2):167-74. PubMed ID: 15943558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of breast cancer screening behavior in women with a strong family history of the disease.
    Price MA; Butow PN; Charles M; Bullen T; Meiser B; McKinley JM; McLachlan SA; Phillips KA; ;
    Breast Cancer Res Treat; 2010 Nov; 124(2):509-19. PubMed ID: 20364401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?
    Haas JS; Kaplan CP; Gregorich SE; Pérez-Stable EJ; Des Jarlais G
    J Gen Intern Med; 2004 Apr; 19(4):302-9. PubMed ID: 15061738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram.
    Hardesty LA; Lind KE; Gutierrez EJ
    J Am Coll Radiol; 2016 Sep; 13(9):1032-8. PubMed ID: 27233908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.
    Bober SL; Hoke LA; Duda RB; Tung NM
    J Genet Couns; 2007 Dec; 16(6):755-62. PubMed ID: 17674165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening Mammography: Patient Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    Amornsiripanitch N; Mangano M; Niell BL
    AJR Am J Roentgenol; 2017 May; 208(5):1163-1170. PubMed ID: 28225643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflicting national recommendations and the use of screening mammography: does the physician's recommendation matter?
    Taplin SH; Urban N; Taylor VM; Savarino J
    J Am Board Fam Pract; 1997; 10(2):88-95. PubMed ID: 9071688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a telephone counseling intervention on transitions in stage of change and adherence to interval mammography screening (United States).
    Carney PA; Harwood BG; Greene MA; Goodrich ME
    Cancer Causes Control; 2005 Sep; 16(7):799-807. PubMed ID: 16132790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-schedule mammography rescreening in the National Cancer Screening Program for breast cancer in Korea.
    Oh D; Jung DW; Jun JK; Jung KW; Lee HY; Park EC; Choi KS
    Asian Pac J Cancer Prev; 2011; 12(11):2865-70. PubMed ID: 22393955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
    Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining compliance with screening mammography.
    Beaulieu MD; Béland F; Roy D; Falardeau M; Hébert G
    CMAJ; 1996 May; 154(9):1335-43. PubMed ID: 8616736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
    Peshkin BN; Schwartz MD; Isaacs C; Hughes C; Main D; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1115-8. PubMed ID: 12376518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing U.S. women's interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center.
    Austin JD; James E; Perez RL; Mazza GL; Kling JM; Fraker J; Mina L; Banerjee I; Sharpe R; Patel BK
    BMC Womens Health; 2024 Jun; 24(1):359. PubMed ID: 38907193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Age, Race, and Socioeconomic Status on Women's Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    Amornsiripanitch N; Ameri SM; Goldberg RJ
    Acad Radiol; 2021 May; 28(5):655-663. PubMed ID: 32376184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient adherence to family practitioners' recommendations for breast cancer screening: a historical cohort study.
    Giveon S; Kahan E
    Fam Pract; 2000 Feb; 17(1):42-5. PubMed ID: 10673487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single-arm trial of personalized risk communication.
    Xie Z; Wenger N; Stanton AL; Sepucha K; Kaplan C; Madlensky L; Elashoff D; Trent J; Petruse A; Johansen L; Layton T; Naeim A
    Psychooncology; 2019 Nov; 28(11):2226-2232. PubMed ID: 31461546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.